July 24 (Reuters) - Outlook Therapeutics said on Friday the U.S. Food and Drug Administration has approved its drug for a type of eye disease that can cause vision loss. The New Jersey-based company was seeking approval for Lytenava to treat wet age-related macular degeneration (AMD),

A generic version of the allergy medication Zyrtec is under recall across the U.S. over cross-contamination concerns.

The new findings position Lilly to file an application for the highly anticipated medicine, but also leave some questions about the additive benefits a “triple-G” drug has on heart health.

During the 6-year period, 199 new indications for solid tumors were approved by the FDA; 138 (69.3%) were also approved by EMA and 124 (62.3%) by ANVISA. Discrepancies between approved labels and the primary end point population occurred in 10.0% of FDA ...

A nationwide recall is in effect for levothyroxine sodium tablets distributed by Major Pharmaceuticals. Here’s how to tell if your meds are affected.

Whatever one’s preferred approach, both prohibition and reform depend on the availability of effective treatment and recovery services.